Literature DB >> 10421117

Potassium-channel opener cardioplegia is superior to St. Thomas' solution in the intact animal.

A M Jayawant1, E R Stephenson, G S Matte, G A Prophet, K F LaNoue, J W Griffith, R J Damiano.   

Abstract

BACKGROUND: In isolated hearts, the potassium-channel opener pinacidil is an effective cardioplegic agent. This study tested the hypothesis that pinacidil is superior to St. Thomas' solution in the more clinically relevant intact animal.
METHODS: Sixteen pigs were placed on full cardiopulmonary bypass. Hearts underwent 2 hours of global ischemia (10 degrees to 15 degrees C). Either St. Thomas' or 100 micromol/L pinacidil was administered every 20 minutes (10 mL/kg). Preischemic and postreperfusion slopes of the preload-recruitable stroke work relationship were determined. Changes in myocardial adenine nucleotide levels and cellular ultrastructure were analyzed.
RESULTS: Pinacidil cardioplegia resulted in an insignificant change in the slope of the preload-recruitable stroke work relationship (40.6+/-2.1 mm Hg/mm before ischemia and 36.5+/-3.7 mm Hg/mm after ischemia; p = 0.466). In contrast, St. Thomas' solution resulted in a significant decrease in the slope after reperfusion (34.3+/-5.5 mm Hg/mm and 13.5+/-2.3 mm Hg/mm; p = 0.003). Adenine nucleotide levels, myocardial tissue water, and ultrastructural changes were similar between groups.
CONCLUSIONS: Pinacidil ameliorated myocardial stunning associated with traditional hyperkalemic cardioplegia without causing significant differences in cellular metabolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421117     DOI: 10.1016/s0003-4975(99)00446-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Protective effects of hyperpolarizing cardioplegia with pinacidil on myocardium in rats.

Authors:  Zhiwei Hu; Kailun Zhang; Wendong Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

Review 2.  Transplantation of Hearts Donated after Circulatory Death.

Authors:  Christopher W White; Simon J Messer; Stephen R Large; Jennifer Conway; Daniel H Kim; Demetrios J Kutsogiannis; Jayan Nagendran; Darren H Freed
Journal:  Front Cardiovasc Med       Date:  2018-02-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.